文献速递儿童感染儿童呼吸

美国儿童医院COVID-19早期住院经验

Early Experience of COVID-19 in a US Children's Hospital.
PubMed 文献 · Pediatrics · 2020-07-17

48%超过12岁,29%小于60天。慢病患儿最重,免疫抑制者79%为轻症,报告1例死亡。

要点

  • 住院COVID-19患儿多小于60天或大于12岁。
  • 慢病患儿病情最重,免疫抑制患儿多为轻症。
  • 白细胞与CRP升高与病情严重程度相关。

核心结论

  • 住院COVID-19患儿多数为小于60天或大于12岁者,部分需ICU支持,免疫抑制患儿病程并不比其他儿童更重。
  • 白细胞计数和C反应蛋白升高与更重的病情严重程度相关。

研究设计与样本

  • 单中心回顾性队列研究,纳入美国Steven and Alexandra Cohen Children's Medical Center at Northwell Health住院的22岁以下COVID-19感染患儿。

主要发现

  • 中位年龄10.3岁(四分位距1.4个月至16.3岁),48%超过12岁,29%小于60天。
  • 86%有发热,60%有下呼吸道症状或体征,62%有胃肠道症状。
  • 病情严重程度在小于60天婴儿中最低、在慢病儿童中最高,79%免疫抑制患儿为轻症。
  • 与轻中度疾病相比,重症患者白细胞计数升高(P = .0027),C反应蛋白水平升高(P = .0192)。

关键数值与推荐

  • 重症与轻中度相比:白细胞计数升高P = .0027,C反应蛋白升高P = .0192。
  • 79%的免疫抑制患儿为轻症。

临床怎么用

  • 对住院COVID-19患儿应关注小于60天婴儿及大于12岁青少年,并评估ICU与呼吸支持需求。
  • 可将白细胞计数和C反应蛋白升高作为病情更重的提示指标。
  • 免疫抑制并非更重病程的必然预测因素,需结合临床综合判断。

局限性

  • 原文未报告多中心验证或更长期随访数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We aim to describe the demographics, clinical presentation, hospital course, and severity of pediatric inpatients with coronavirus disease 2019 (COVID-19), with an emphasis on healthy, immunocompromised, and chronically ill children. METHODS: We conducted a single-center retrospective cohort study of hospitalized children aged younger than 22 years with COVID-19 infection at Steven and Alexandra Cohen Children's Medical Center at Northwell Health. Cases were identified from patients with fever and/or respiratory symptoms who underwent a nucleic acid amplification-based test for severe acute respiratory syndrome coronavirus 2. RESULTS: Sixty-five patients were identified. The median age was 10.3 years (interquartile range, 1.4 months to 16.3 years), with 48% of patients older than 12 years and 29% of patients younger than 60 days of age. Fever was present in 86% of patients, lower respiratory symptoms or signs in 60%, and gastrointestinal symptoms in 62%. Thirty-five percent of patients required ICU care. The white blood cell count was elevated in severe disease (P = .0027), as was the C-reactive protein level (P = .0192), compared with mild and moderate disease. Respiratory support was required in 34% of patients. Severity was lowest in infants younger than 60 days of age and highest in chronically ill children; 79% of immunocompromised children had mild disease. One death was reported. CONCLUSIONS: Among children who are hospitalized for COVID-19, most are younger than 60 days or older than 12 years of age. Children may have severe infection requiring intensive care support. The clinical course of immunocompromised patients was not more severe than that of other children. Elevated white blood cell count and C-reactive protein level are associated with greater illness severity.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Kainth MK, Goenka PK, Williamson KA, et al. Early Experience of COVID-19 in a US Children's Hospital. Pediatrics. 2020. PMID: 32680880. doi:10.1542/peds.2020-003186

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。